Property	Value
Status
Version
Ad File
Disable Ads Flag
Environment
Moat Init
Moat Ready
Contextual Ready
Contextual URL
Contextual Initial Segments
Contextual Used Segments
AdUnit
SubAdUnit
Custom Targeting
Ad Events
Invalid Ad Sizes

Christen Maria Mowad MD Advisory Board

Robert T. Brodell MD, FAAD Editor-in-Chief

Jane M. Grant-Kels MD, FAAD Advisory Board

See All Experts

featured

Published in Dermatology

Expert Opinion / My Approach · May 18, 2015

MY APPROACH to the Treatment of Cutaneous (Non-Genital) Warts

Written by

Ramya Kollipara MD

Written by

Stephen K. Tyring MD, PhD

Save Recommend

Sign in to PracticeUpdate

Only registered members have full access to PracticeUpdate content.

Sign in

Not a member?

Join for free

story of the week

Assessing Skin Cancer Diagnosis Accuracy by Lesion Type, Physician Experience, and Examination Method

JAMA Dermatol · November 27, 2024
featured

Doxycycline Post-Exposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention

JAMA Dermatol · November 27, 2024
story of the week

Association Between 5α-Reductase Inhibitor Use for Dermatologic Conditions and the Risk of Breast or Gynecologic Cancers

J Am Acad Dermatol · November 26, 2024

updated
featured

Efficacy of Treatment With Secukinumab in Patients With Hidradenitis Suppurativa

J Eur Acad Dermatol Venereol · November 26, 2024

updated
story of the week

Local Recurrence, Metastasis, and Mortality Rates Among Patients With Thin and In Situ Melanomas

J Am Acad Dermatol · November 26, 2024

updated
featured

Suicidal and Self-Injurious Behaviors Among Patients With Psoriasis or Psoriatic Arthritis Treated With Biologics

J Am Acad Dermatol · November 26, 2024

updated
featured

Efficacy and Safety of Combined Topical 17α-Ethinyl Estradiol With Minoxidil vs Topical Minoxidil Alone in Patients With Female Pattern Hair Loss

Clin Exp Dermatol · November 26, 2024

updated
featured

Clinical Features and Treatment Outcomes Among Patients With Primary Cutaneous B-Cell Lymphomas

Int. J. Dermatol · November 21, 2024
featured

Clinical Characteristics and Outcomes of DPP-4 Inhibitor–Associated Bullous Pemphigoid

J Am Acad Dermatol · November 21, 2024
featured

Efficacy and Safety of Tofacitinib vs Azathioprine in Patients With Alopecia Areata and Its Variants

Arch Dermatol Res · November 20, 2024

updated
featured

Outcomes of Down-Titration in Patients With Severe Scalp Alopecia Areata Initially Treated With Baricitinib 4 mg

J Am Acad Dermatol · November 20, 2024

MY APPROACH to the Treatment of Cutaneous (Non-Genital) Warts

Further Reading

Assessing Skin Cancer Diagnosis Accuracy by Lesion Type, Physician Experience, and Examination Method

Doxycycline Post-Exposure Prophylaxis for Bacterial Sexually Transmitted Infection Prevention

Association Between 5α-Reductase Inhibitor Use for Dermatologic Conditions and the Risk of Breast or Gynecologic Cancers

Efficacy of Treatment With Secukinumab in Patients With Hidradenitis Suppurativa

Local Recurrence, Metastasis, and Mortality Rates Among Patients With Thin and In Situ Melanomas

Suicidal and Self-Injurious Behaviors Among Patients With Psoriasis or Psoriatic Arthritis Treated With Biologics

Efficacy and Safety of Combined Topical 17α-Ethinyl Estradiol With Minoxidil vs Topical Minoxidil Alone in Patients With Female Pattern Hair Loss

Clinical Features and Treatment Outcomes Among Patients With Primary Cutaneous B-Cell Lymphomas

Clinical Characteristics and Outcomes of DPP-4 Inhibitor–Associated Bullous Pemphigoid

Efficacy and Safety of Tofacitinib vs Azathioprine in Patients With Alopecia Areata and Its Variants

Outcomes of Down-Titration in Patients With Severe Scalp Alopecia Areata Initially Treated With Baricitinib 4 mg

Recently Updated